Entry |
|
Name |
Antiulcer drugs |
Class |
|
Pathway map |

|
Compound |
D00295 | Cimetidine (JP18/USP/INN) |
D00318 | Famotidine (JP18/USP/INN) |
D00355 | Lansoprazole (JP18/USP/INN) |
D00419 | Misoprostol (JAN/USP/INN) |
D00440 | Nizatidine (JP18/USP/INN) |
D00455 | Omeprazole (JP18/USP/INN) |
D00481 | Propantheline bromide (JP18/USP/INN) |
D00673 | Ranitidine hydrochloride (JP18/USP) |
D00724 | Rabeprazole sodium (JP18/USP) |
D00731 | Magnesium hydroxide (JAN/USP) |
D00932 | Calcium carbonate (USP) |
D01152 | Oxethazaine (JP18/USAN) |
D01165 | Piperidolate hydrochloride (JAN) |
D01167 | Magnesium oxide (JP18/USP) |
D01203 | Sodium bicarbonate (JP18/USP) |
D01207 | Omeprazole sodium (USAN) |
D01297 | Pirenzepine hydrochloride (USAN) |
D01377 | Prifinium bromide (JAN/INN) |
D01451 | Scopolamine butylbromide (JP18) |
D01467 | Roxatidine acetate hydrochloride (JP18/USAN) |
D01491 | Butropium bromide (JP18/INN) |
D01658 | Irsogladine maleate (JP18) |
D01815 | Oxapium iodide (JP18/INN) |
D01818 | Proglumide (JP18/USAN/INN) |
D01875 | Tiquizium bromide (JAN/INN) |
D01891 | Enprostil (JAN/USAN/INN) |
D01920 | Tenatoprazole (JAN/INN) |
D01984 | Esomeprazole magnesium (USP) |
D01991 | Ecabet sodium hydrate (JP18) |
D02266 | Cetraxate hydrochloride (JP18/USAN) |
D02416 | Aluminum hydroxide (USP) |
D02535 | Timepidium bromide hydrate (JP18) |
D02593 | Pantoprazole sodium (USP) |
D02706 | Sodium gualenate hydrate (JAN) |
D03236 | Synthetic aluminum silicate (JP18) |
D03237 | Natural aluminum silicate (JP18) |
D03271 | Magnesium trisilicate (USP) |
D03503 | Cimetidine hydrochloride (USP) |
D04056 | Esomeprazole sodium (USAN) |
D04839 | Magnesium silicate (JP18/NF) |
D05259 | Omeprazole magnesium (USP) |
D05261 | Omeprazole sodium injection (JAN) |
D05276 | Pirenzepine hydrochloride hydrate (JP18) |
D05353 | Pantoprazole (USAN/INN) |
D05699 | Ranitidine bismuth citrate (USAN) |
|
Reference |
|
Authors |
Fukai S. |
Title |
[New Drugs Today (6th ed)] (In Japanese) |
Journal |
Jiho (1995) |
Reference |
|
Authors |
David AW, Thomas LL, William OF. |
Title |
Foye's Principles of Medicinal Chemistry (5th ed) |
Journal |
Lippincott Williams & Wilkins (2002) |
Reference |
|
Authors |
Walter S. |
Title |
Drug Discovery: A History |
Journal |
Wiley (2005) |
Reference |
|
Authors |
Japan Pharmaceutical Association (ed). |
Title |
[Face of Medecine: Structure Activity Relationship] (In Japanese) |
Journal |
Yakuji Nippo (1999) |
Reference |
|
Authors |
Noguchi S, Hibino S (eds). |
Title |
[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese) |
Journal |
Hirokawa (2002) |
Reference |
|
Authors |
Tanaka C, Kato R (eds). |
Title |
[New Pharmacology (4th ed)] (In Japanese) |
Journal |
Nankodo (2002) |
Reference |
|
Authors |
Sachs G, Shin JM, Howden CW |
Title |
Review article: the clinical pharmacology of proton pump inhibitors. |
Journal |
|
Reference |
|
Authors |
Scarpignato C, Pelosini I |
Title |
Review article: the opportunities and benefits of extended acid suppression. |
Journal |
|
Reference |
|
Authors |
Der G. |
Title |
An overview of proton pump inhibitors. |
Journal |
|